<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xml:lang="en" lang="en">
<head>
<meta charset="utf-8"/>
<title>Functional Groups: Characteristics and Interconversions</title>
<link rel="stylesheet" href="../styles/stylesheet.css" type="text/css"/>
</head>
<body>
<p class="noindent">&#xA0;</p>
<a id="page_ii" class="page">page ii, Functional Groups: Characteristics and Interconversions</a>
<p class="noindent">&#xA0;</p>
<table class="width100a">
<tr>
<td style="vertical-align:top;" class="borderb"><p class="head1"><b>Functional Groups:<br/> Characteristics and<br/> Interconversions</b></p></td>
</tr>
<tr>
<td style="vertical-align:top;"><p class="author"><b>G. Denis Meakins</b></p></td>
</tr>
<tr>
<td style="vertical-align:top;"><p class="author1">Emeritus Fellow, Keble College, Oxford</p></td>
</tr>
</table>
<p class="titl">Series sponsor: <span class="img"><img style="margin-top:-1.2em;" src="../images/titl.jpg" alt="images"/></span></p>
<p class="indent2">AstraZeneca is one of the world&#x2019;s leading pharmaceutical companies with a strong research base. Its skill and innovative ideas in organic chemistry and bioscience create products designed to fight disease in seven key therapeutic areas: cancer, cardiovascular, central nervous system, gastrointestinal, infection, pain control, and respiratory.</p>
<p class="noindent3">AstraZeneca was formed through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK. The company is headquartered in the UK with over 50,000 employees worldwide. R&amp;D centres of excellence are in Sweden, the UK, and USA with R&amp;D headquarters in S&#xF6;dert&#xE4;lje, Sweden.</p>
<p class="noindent3">AstraZeneca is committed to the support of education in chemistry and chemical engineering.</p>
<p class="pub"><img src="../images/pub.jpg" alt="images"/></p>
</body>
</html>
